Showing results (1231-1240 of 1,427) with videos related to
Sort By:
Pageof 143
ESMO Open|February 20, 2021
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trialJ A Ledermann, A C Embleton-Thirsk, T J Perren, et al.Gynecologic Oncology|February 27, 2024
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancerFelicia Roncolato, Madeleine T King, Rachel L O'Connell, et al.Cancer Research Communications|May 7, 2025
P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer OrganoidsBernat Navarro-Serer, Maria F Wissler, Brandi K Glover, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2022
The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancerK E Francis, S I Kim, M Friedlander, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapyNatasha B Leighl, Heather L Shepherd, Phyllis N Butow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell CancerBhavna Oza, Tim Eisen, Eleni Frangou, et al.Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery of a novel class of triazolones as checkpoint kinase inhibitors--hit to lead explorationVibha Oza, Susan Ashwell, Patrick Brassil, et al.Pageof 143